Cargando…

Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging

INTRODUCTION: Randomized and nonrandomized clinical trials have tried to assess whether or not TMR patients experience an increase in myocardial perfusion. However there have been inconsistencies reported in the literature due to the use of different nuclear imaging modalities to test this metric. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwanski, Jessika, Knapp, Shannon M., Avery, Ryan, Oliva, Isabel, Wong, Raymond K., Runyan, Raymond B., Khalpey, Zain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438520/
https://www.ncbi.nlm.nih.gov/pubmed/28526044
http://dx.doi.org/10.1186/s13019-017-0602-8
_version_ 1783237780304822272
author Iwanski, Jessika
Knapp, Shannon M.
Avery, Ryan
Oliva, Isabel
Wong, Raymond K.
Runyan, Raymond B.
Khalpey, Zain
author_facet Iwanski, Jessika
Knapp, Shannon M.
Avery, Ryan
Oliva, Isabel
Wong, Raymond K.
Runyan, Raymond B.
Khalpey, Zain
author_sort Iwanski, Jessika
collection PubMed
description INTRODUCTION: Randomized and nonrandomized clinical trials have tried to assess whether or not TMR patients experience an increase in myocardial perfusion. However there have been inconsistencies reported in the literature due to the use of different nuclear imaging modalities to test this metric. The primary purpose of this meta-analysis was to determine whether SPECT, MUGA and PET scans demonstrate changes in myocardial perfusion between lased and non-lased subjects and whether laser type affects myocardial perfusion. The secondary purpose was to examine the overall effect of laser therapy on clinical outcomes including survival, hospital re-admission and angina reduction. METHODS: Sixteen studies were included in the primary endpoint analysis after excluding all other non-imaging TMR papers. Standardized mean difference was used as the effect size for all quantitative outcomes and log odds ratio was used as the effect size for all binary outcomes. RESULTS: Statistically significant improvements in myocardial perfusion were observed between control and treatment groups in myocardial perfusion at 6-month follow up using PET imaging with a porcine model. However non-significant differences were observed in patients at 3 and 12 months using SPECT, PET or MUGA scans. Both CO(2) and Ho:YAG laser systems demonstrated an increase in myocardial perfusion however this effect was not statistically significant. In addition both laser types displayed statistically significant decreases in patient angina at 3, 6 and 12 months but non-significant increases in survival rates and decreases in hospital re-admissions. CONCLUSION: In order to properly assess myocardial perfusion in TMR subjects, subendocardial perfusion needs to be analyzed via nuclear imaging. PET scans can provide this level of sensitivity and should be utilized in future studies to monitor and detect perfusion changes in lased and non-lased subjects.
format Online
Article
Text
id pubmed-5438520
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54385202017-05-22 Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging Iwanski, Jessika Knapp, Shannon M. Avery, Ryan Oliva, Isabel Wong, Raymond K. Runyan, Raymond B. Khalpey, Zain J Cardiothorac Surg Review INTRODUCTION: Randomized and nonrandomized clinical trials have tried to assess whether or not TMR patients experience an increase in myocardial perfusion. However there have been inconsistencies reported in the literature due to the use of different nuclear imaging modalities to test this metric. The primary purpose of this meta-analysis was to determine whether SPECT, MUGA and PET scans demonstrate changes in myocardial perfusion between lased and non-lased subjects and whether laser type affects myocardial perfusion. The secondary purpose was to examine the overall effect of laser therapy on clinical outcomes including survival, hospital re-admission and angina reduction. METHODS: Sixteen studies were included in the primary endpoint analysis after excluding all other non-imaging TMR papers. Standardized mean difference was used as the effect size for all quantitative outcomes and log odds ratio was used as the effect size for all binary outcomes. RESULTS: Statistically significant improvements in myocardial perfusion were observed between control and treatment groups in myocardial perfusion at 6-month follow up using PET imaging with a porcine model. However non-significant differences were observed in patients at 3 and 12 months using SPECT, PET or MUGA scans. Both CO(2) and Ho:YAG laser systems demonstrated an increase in myocardial perfusion however this effect was not statistically significant. In addition both laser types displayed statistically significant decreases in patient angina at 3, 6 and 12 months but non-significant increases in survival rates and decreases in hospital re-admissions. CONCLUSION: In order to properly assess myocardial perfusion in TMR subjects, subendocardial perfusion needs to be analyzed via nuclear imaging. PET scans can provide this level of sensitivity and should be utilized in future studies to monitor and detect perfusion changes in lased and non-lased subjects. BioMed Central 2017-05-19 /pmc/articles/PMC5438520/ /pubmed/28526044 http://dx.doi.org/10.1186/s13019-017-0602-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Iwanski, Jessika
Knapp, Shannon M.
Avery, Ryan
Oliva, Isabel
Wong, Raymond K.
Runyan, Raymond B.
Khalpey, Zain
Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging
title Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging
title_full Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging
title_fullStr Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging
title_full_unstemmed Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging
title_short Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging
title_sort clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438520/
https://www.ncbi.nlm.nih.gov/pubmed/28526044
http://dx.doi.org/10.1186/s13019-017-0602-8
work_keys_str_mv AT iwanskijessika clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging
AT knappshannonm clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging
AT averyryan clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging
AT olivaisabel clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging
AT wongraymondk clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging
AT runyanraymondb clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging
AT khalpeyzain clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging